Patents by Inventor Angela Dawn Glendenning

Angela Dawn Glendenning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF OCULAR DISEASES USING ENDOTHELIN RECEPTOR ANTAGONISTS
    Publication number: 20240058265
    Abstract: The present disclosure relates to the discovery that certain diseases of the eye that profoundly affect the human visual system and, as a result, quality of life, may be treated using Edonentan or A-182086. Examples of the diseases include, but not limited to, ocular neovascularization, neovascular glaucoma, vascular leak, macular edema, and a neovascular age-related macular degeneration.
    Type: Application
    Filed: October 25, 2023
    Publication date: February 22, 2024
    Inventors: Cheng-Wen Lin, Angela Dawn Glendenning, Sevgi Gurkan
  • PHARMACEUTICAL COMPOSITIONS AND INTRAVITREAL DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF OCULAR DISEASES
    Publication number: 20230414577
    Abstract: The present disclosure relates to a biodegradable ocular implant comprising a biodegradable polymer containing a compound such as Edonentan, or a pharmaceutically acceptable salt thereof. Also disclosed are methods of treatment of ocular diseases with the biodegradable ocular implant and methods of preparation of the same.
    Type: Application
    Filed: September 7, 2023
    Publication date: December 28, 2023
    Inventors: Cheng-Wen Lin, Angela Dawn Glendenning, Sevgi Gurkan
  • Pharmaceutical compositions and intravitreal drug delivery systems for the treatment of ocular diseases
    Patent number: 11786510
    Abstract: The present disclosure relates to a biodegradable ocular implant comprising a biodegradable polymer containing a compound such as Edonentan, or a pharmaceutically acceptable salt thereof. Also disclosed are methods of treatment of ocular diseases with the biodegradable ocular implant and methods of preparation of the same.
    Type: Grant
    Filed: November 30, 2022
    Date of Patent: October 17, 2023
    Assignee: Perfuse Therapeutics, Inc.
    Inventors: Cheng-Wen Lin, Angela Dawn Glendenning, Sevgi Gurkan
  • PHARMACEUTICAL COMPOSITIONS AND INTRAVITREAL DRUG DELIVERY SYSTEMS FOR THE TREATMENT OF OCULAR DISEASES
    Publication number: 20230105507
    Abstract: The present disclosure relates to a biodegradable ocular implant comprising a biodegradable polymer containing a compound such as Edonentan, or a pharmaceutically acceptable salt thereof. Also disclosed are methods of treatment of ocular diseases with the biodegradable ocular implant and methods of preparation of the same.
    Type: Application
    Filed: November 30, 2022
    Publication date: April 6, 2023
    Inventors: Cheng-Wen Lin, Angela Dawn Glendenning, Sevgi Gurkan